Also read: I have not retired, I just stood down from this Test because I am not in form ... 2025), India scored 141 for six in its second innings and leads by 145. After bowling out Australia ...
India vs Australia Highlights, 5th Test Day 2: Rishabh Pant slammed a 29-ball half-century to drive his team to a 145-run lead with four wickets left after an intense day two. At the close in ...
Second quickest Test half-century for India ... India, despite Bumrah's absence, managed to eke out a 4-run lead by bowling out Australia for 181. Australia bowlers led by Scott Boland put ...
Nitish Kumar Reddy of India celebrates after dismissing Pat Cummins of Australia. Photo / Getty Images After dismissing India for 185 on day one, Australia go into day two looking to consolidate ...
India take a narrow four-run lead. Reports coming in that Jasprit Bumrah has headed to hospital for scans. he is off the field for a long time. I stood down (from Sydney Test) that is what I would ...
Bumrah will have another opportunity to lead the team in the all-important fifth Test, which India must win to level the series 2-2 and retain the Border Gavaskar Trophy.
Australia, leading the series 2-1, have their sights set on the World Test Championship final. They will debut all-rounder Beau Webster, replacing Mitchell Marsh, who has struggled with the bat.
India skipper Rohit Sharma has opted to rest in the fifth and final Test match against Australia in Sydney. In his absence, Jasprit Bumrah, the designated vice-captain, is likely to lead India for ...
ALSO READ: IND vs AUS 5th Test: Will Rishabh Pant be dropped from India's Playing 11? Jasprit Bumrah to lead in 5th Test Jasprit Bumrah had previously captained the team during the first Test in Perth ...
According to the reports, Rishabh Pant will retain his position as the wicketkeeper and Dhruv Jurel might have to wait for his place in the Test side after playing the first Test in Perth which ...
"But now that we have a simple nasal swab test to detect other endotypes, we can start to move the needle on developing biologics for T17-high and low-low disease." This rapid test for asthma ...